PEROSA, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 2.486
EU - Europa 2.027
AS - Asia 1.339
SA - Sud America 148
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 6.019
Nazione #
US - Stati Uniti d'America 2.458
CN - Cina 655
IE - Irlanda 544
UA - Ucraina 419
IT - Italia 346
SG - Singapore 338
SE - Svezia 222
RU - Federazione Russa 171
HK - Hong Kong 141
BR - Brasile 136
TR - Turchia 100
FI - Finlandia 93
FR - Francia 69
GB - Regno Unito 54
DE - Germania 52
VN - Vietnam 40
IN - India 28
CA - Canada 18
PL - Polonia 13
BE - Belgio 12
CZ - Repubblica Ceca 11
BD - Bangladesh 10
ZA - Sudafrica 9
SA - Arabia Saudita 7
AR - Argentina 6
IQ - Iraq 5
NL - Olanda 5
ES - Italia 4
MX - Messico 4
EU - Europa 3
IR - Iran 3
LT - Lituania 3
SI - Slovenia 3
UZ - Uzbekistan 3
AT - Austria 2
CO - Colombia 2
JO - Giordania 2
MA - Marocco 2
PA - Panama 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
JP - Giappone 1
LB - Libano 1
LK - Sri Lanka 1
MC - Monaco 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SN - Senegal 1
VE - Venezuela 1
Totale 6.019
Città #
Dublin 544
Chandler 386
Dearborn 302
Dallas 295
Jacksonville 293
Nanjing 158
Hong Kong 141
Beijing 134
Singapore 123
Nyköping 109
Ashburn 90
Santa Clara 69
Nanchang 67
Princeton 60
San Mateo 56
Wilmington 49
Moscow 45
Helsinki 36
The Dalles 35
Ann Arbor 33
Kunming 33
Shenyang 33
Boardman 32
Tianjin 30
Munich 25
Rome 25
Jiaxing 23
Council Bluffs 20
Milan 19
Changsha 16
Des Moines 15
Hebei 15
Los Angeles 14
Woodbridge 14
Hangzhou 13
São Paulo 13
Brussels 12
Ho Chi Minh City 12
New York 12
Brno 11
Hanoi 11
Changchun 10
Florence 9
Hilden 9
Jinan 9
Ningbo 9
Bari 8
Bologna 8
Lanzhou 8
Napoli 7
Radomsko 7
Shanghai 7
Zhengzhou 7
Catania 6
Guangzhou 6
London 6
Norwalk 6
Amsterdam 5
Chicago 5
Hefei 5
Nuremberg 5
Ottawa 5
Rio de Janeiro 5
Riyadh 5
Taizhou 5
Auburn Hills 4
Catanzaro 4
Johannesburg 4
Livorno 4
Peccioli 4
Reggio Calabria 4
Saint Petersburg 4
Sassari 4
Serra 4
Stevenage 4
Toronto 4
Verona 4
Volla 4
Washington 4
Xi'an 4
Ankara 3
Atlanta 3
Brooklyn 3
Bruino 3
Cape Town 3
Genoa 3
Koper 3
Leduc 3
Manchester 3
Messina 3
Naples 3
Phoenix 3
Porto Alegre 3
Pune 3
Tashkent 3
Torino 3
Trieste 3
Villacidro 3
Warsaw 3
Wuhan 3
Totale 3.705
Nome #
Anticorpi anti-idiotipo 272
Anticorpi monoclonali anti-idiotipo (Ab2) anti-CD4 inducono anticorpi anti-CD4 in un sistema singenico 209
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 198
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 158
Purificazione delle Immunoglobuline 129
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 113
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 107
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 103
Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies 102
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 100
Le vaccinazioni nei pazienti con immunodeficienza 100
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 99
SOLUBLE CD4 ANTIGEN REACTIVITY IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS: IS IT SPECIFIC? 98
Cloning and chromosomal localization of a cDNA encoding a mitochondrial porin from Drosophila melanogaster 98
Caratteristiche ed indicazioni terapeutiche dei preparati di immunoglobuline umane 98
Studio funzionale e limiti terapeutici di anticorpi anti-idiotipo (Ab2) anti-CD4 nella infezione da HIV 95
L'ospite immunocompromesso: un complesso sindromico in espansione. Quadri clinici, aspetti immunologici e prospettive terapeutiche 95
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 94
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 94
Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases 94
Uso di di un anticorpo monoclonale antiidiotipo di un anticorpo monoclonale anti-CD4 in pazienti con artrite reumatoide 93
Antiidiotypic monoclonal antibodies to anti HLA Class II monoclonal antibodies. Potential application in the treatment of autoimmune diseases 92
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 92
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 92
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 90
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 90
L'isoelettrofocalizzazione nello studio delle gammapatie monoclonali 89
Mieloma multiplo e gammapatie monoclonali:quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 89
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 88
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 87
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 87
BETA -MICROGLOBULIN-FREE HEAVY CHAIN FHC OF HLA CLASS I ANTIGEN IN PATIENTS WITH HODGKIN'S AND NON-HODGKIN'S LYMPHOMAS 86
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 86
Subclass and clonotypic profiles of serum AB elicited with the "human CD4 internal AG" mab F16-16D7 (16D7) in 4 patients with systemic lupus erythematosus 85
Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated- denatured chains of an anti-CD4 monoclonal antibody 85
CD4 mimicry by anti-idiotypic mAb (mAb2) F16-16D7 (16D7). Immunochemical and sequence analysis 85
Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis 84
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 84
Monoclonal antibodies in the immunotherapy of autoimmune diseases 83
Immunoterapia: realta' e fantasia 83
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 82
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti HLA-B7,B27 monoclonal antibodies 82
Antiidiotype to anti-CD4 monoclonal antibody (mAb) as surrogate of human CD4 antigen (Ag) for active immunotherapy in autoimmune diseases 82
Serological methods to detect anti-idiotypic antibodies 81
Studi in vitro dell'attivita' antiallergica del Fenoterolo 79
Soluble CD4 and commercial immunoglobulin 79
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 78
Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies 77
Human immunoglobulins in therapy. Rationale and clinical applications 77
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 77
Immunogenicity of 2 Idiotopes with A Different Immunoglobulin- Chain Distribution Expressed on the Same Anti-Cd4-Mab 75
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification 75
Vasculiti primarie sistemiche 75
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 75
La difesa immunologica contro i tumori: dalla teoria alla clinica 75
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 74
Le immunoglobuline in terapia: lo stato dell'arte 71
Le gammapatie monoclonali: moderno inquadramento diagnostico e prognostico 70
Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 68
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 68
THU0164 Subclinical atherosclerosis and cardiovascular events in italian patients with rheumatoid arthritis: results from multicenter girrcs (gruppo italiano di ricerca in reumatologia clinica e sperimentale) study 58
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: Findings from a 3-year, multicentre, prospective, observational study 43
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 37
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 36
Dissecting the clinical heterogeneity of adult-onset Still's disease: Results from a multi-dimensional characterization and stratification 36
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 35
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 34
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 31
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 24
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 18
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir 3
Pain catastrophizing and its domains significantly impact rheumatoid arthritis disease activity 2
Totale 6.083
Categoria #
all - tutte 29.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 62 70 23 63 69 2 0
2021/2022346 57 3 2 6 29 13 15 40 43 29 31 78
2022/20231.492 110 32 32 124 115 174 1 139 683 22 35 25
2023/2024207 33 17 19 19 29 34 1 22 0 5 2 26
2024/2025867 36 1 15 26 31 172 47 75 228 52 89 95
2025/2026849 106 188 330 151 64 10 0 0 0 0 0 0
Totale 6.083